Dan Carlson, Ph.D.

Chief Scientific Officer and SVP of Research & Development @ Recombinetics arrow icon

Known information

About Recombinetics

Recombinetics specializes in animal gene editing, focusing on biomedical research, regenerative medicine, and animal agriculture, with a significant role in xenotransplantation through its merger with Makana Therapeutics.

report flag Report inaccurate information
Unlock exclusive insights

Sign up to reveal more information.

loader Sign up for free